SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Establishing cost-effectiveness threshold in China: a community survey of willingness to pay for a healthy life year
16 references·0 citing·43 second hop
Establishing cost-effectiveness threshold in China: a community survey of willingness to pay for a healthy life year (2024)Establishing cost-effectiveness threshold…Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward (2019)Multicriteria Decision Analys…10 years of health-care reform in China: progress and gaps in Universal Health Coverage (2019)10 years of health-care refor…On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review (2018)On what basis are medical cos…Estimating an EQ-5D-5L Value Set for China (2017)Estimating an EQ-5D-5L Value …Understanding and improving the one and three times GDP per capita cost-effectiveness thresholds (2016)Understanding and improving t…On the Estimation of the Cost-Effectiveness Threshold: Why, What, How? (2016)On the Estimation of the Cost…Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research (2016)Country-Level Cost-Effectiven…Cost–effectiveness thresholds: pros and cons (2016)Cost–effectiveness thresholds…Cost-Effectiveness in Health and Medicine (2016)Cost-Effectiveness in Health …Systematic overview of cost–effectiveness thresholds in ten countries across four continents (2015)Systematic overview of cost–e…WTP for a QALY and health states: More money for severer health states? (2013)WTP for a QALY and health sta…Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008 (2010)Population health status in C…International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? (2009)International survey on willi…The NICE Cost-Effectiveness Threshold (2008)The NICE Cost-Effectiveness T…Doing It Now or Later (1999)Doing It Now or LaterReport of NOAA Panel on Contingent Valuation (1993)Report of NOAA Panel on Conti…Toward a positive theory of consumer choice (1980)A Theory of Rational Addiction (1988)Anomalies: The Endowment Effect, Loss Aversion, and Status Quo Bias (1991)Discrete Choice Methods with Simulation (2001)Time Discounting and Time Preference: A Critical Review (2002)A Model of Reference-Dependent Preferences (2006)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Recommendations for Reporting Cost-effectiveness Analyses (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)Productivity Costs in Economic Evaluations: Past, Present, Future (2013)The Willingness to Pay for a Quality Adjusted Life Year: A Review of the Empirical Literature (2014)The Value of a Statistical Life: A Critical Review of Market Estimates Throughout the World (2003)Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold (2014)The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought (2016)The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billion (2020)Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures (2023)Global health 2035: a world converging within a generation (2013)Thresholds for the cost–effectiveness of interventions: alternative approaches (2014)Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold (2015)Cost-Effectiveness Thresholds: the Past, the Present and the Future (2018)An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations (2021)Quantifying the global burden of mental disorders and their economic value (2022)Modeling Valuations for EuroQol Health States (1997)Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) (2011)Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores (2017)Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries (2018)Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol (2019)The Links Between Education and Health (1995)Healthy life expectancy for 187 countries, 1990–2010: a systematic analysis for the Global Burden Disease Study 2010 (2012)¿Qué es una intervención sanitaria eficiente en España en 2020? (2019)Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life (2021)Estimating the range of incremental cost-effectiveness thresholds for healthcare based on willingness to pay and GDP per capita: A systematic review (2022)A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States (2020)The cost-effectiveness of digital health interventions: A systematic review of the literature (2022)Does long-term care insurance reduce hospital utilization and medical expenditures? Evidence from China (2020)Towards universal health coverage: lessons from 10 years of healthcare reform in China (2020)Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China (2021)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3] (2018)Simulating the Potential Impacts of COVID-19 School Closures on Schooling and Learning Outcomes: A Set of Global Estimates (2020)Contingent Valuation: Controversies and Evidence (2001)The contingent valuation method: a review (2003)Incentive and informational properties of preference questions (2007)
this work references cited by second hop

References

  • 1999Doing It Now or Later3,127 cited
  • 1993Report of NOAA Panel on Contingent Valuation1,946 cited
  • 2016Cost-Effectiveness in Health and Medicine1,550 cited
  • 201910 years of health-care reform in China: progress and gaps in Universal Health Coverage1,258 cited
  • 2016Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research889 cited
  • 2008The NICE Cost-Effectiveness Threshold868 cited
  • 2016Cost–effectiveness thresholds: pros and cons789 cited
  • 2017Estimating an EQ-5D-5L Value Set for China697 cited
  • 2009International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?692 cited
  • 2018On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review363 cited
  • 2010Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008225 cited
  • 2016Understanding and improving the one and three times GDP per capita cost-effectiveness thresholds215 cited
  • 2019Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward174 cited
  • 2016On the Estimation of the Cost-Effectiveness Threshold: Why, What, How?

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

170 cited
  • 2015Systematic overview of cost–effectiveness thresholds in ten countries across four continents154 cited
  • 2013WTP for a QALY and health states: More money for severer health states?135 cited
  • Cited by

    No citing works inside the corpus for this window.